| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Kai Siang Chan, Vishal G Shelat, Hsien Min Low, Jee Keem Lo. Is the extent of functional liver remnant increase truly "functional"? A single-institution case series of patients with Associating Liver Partition and Portal vein ligation for Staged hepatectomy (ALPPS). Clinical and experimental hepatology. vol 9. issue 1. 2023-04-17. PMID:37064831. |
associating liver partition and portal vein ligation for staged hepatectomy (alpps) aims to induce rapid hypertrophy of the future liver remnant (flr) to reduce the risk of post-hepatectomy liver failure (phlf). |
2023-04-17 |
2023-08-14 |
Not clear |
| Yining Wu, Shenjian Ou, Xiwen Liao, Chuangye Han, Chengkun Yang, Wei Qin, Yufeng Tan, Quan Lao, Tao Peng, Xinping Y. Massive Hepatocellular Carcinoma with Situs Inversus Totalis Achieved a Complete Response Following Camrelizumab Plus Apatinib and Combined with Two-Stage Hepatectomy: A Case Report. Pharmacogenomics and personalized medicine. vol 16. 2023-02-14. PMID:36785780. |
preoperative volume assessment of portal vein ligation (pvl) revealed inadequate hypertrophy of flr. |
2023-02-14 |
2023-08-14 |
Not clear |
| Xinwei Chang, Remon Korenblik, Bram Olij, Robrecht R M M Knapen, Christiaan van der Leij, Daniel Heise, Marcel den Dulk, Ulf P Neumann, Frank G Schaap, Ronald M van Dam, Steven W M Olde Damin. Influence of cholestasis on portal vein embolization-induced hypertrophy of the future liver remnant. Langenbeck's archives of surgery. vol 408. issue 1. 2023-01-21. PMID:36680689. |
here, we study the impact of cholestasis on portal vein embolization (pve)-induced hypertrophy of the future liver remnant (flr). |
2023-01-21 |
2023-08-14 |
Not clear |
| Fengming Yi, Wei Zhang, Long Fen. Efficacy and safety of different options for liver regeneration of future liver remnant in patients with liver malignancies: a systematic review and network meta-analysis. World journal of surgical oncology. vol 20. issue 1. 2022-12-16. PMID:36527081. |
several treatments induce liver hypertrophy for patients with liver malignancies but insufficient future liver remnant (flr). |
2022-12-16 |
2023-08-14 |
Not clear |
| Jens M Theysohn, Aydin Demircioglu, Malte Kleditzsch, Johannes M Ludwig, Manuel Weber, Lale Umutlu, Yan Li, Malte Kircher, Constantin Lapa, Andreas Buck, Michael Koehler, Moritz Wildgruber, Christian M Lange, Xavier Palard, Etienne Garin, Ken Herrmann, Michael Forsting, Felix Nens. Prediction of left lobe hypertrophy after right lobe radioembolization of the liver using a clinical data model with external validation. Scientific reports. vol 12. issue 1. 2022-12-01. PMID:36456637. |
to become surgical candidate, hypertrophy of the left liver lobe to > 40% (future liver remnant, flr) is mandatory, which can develop after re. |
2022-12-01 |
2023-08-14 |
Not clear |
| Jens M Theysohn, Aydin Demircioglu, Malte Kleditzsch, Johannes M Ludwig, Manuel Weber, Lale Umutlu, Yan Li, Malte Kircher, Constantin Lapa, Andreas Buck, Michael Koehler, Moritz Wildgruber, Christian M Lange, Xavier Palard, Etienne Garin, Ken Herrmann, Michael Forsting, Felix Nens. Prediction of left lobe hypertrophy after right lobe radioembolization of the liver using a clinical data model with external validation. Scientific reports. vol 12. issue 1. 2022-12-01. PMID:36456637. |
this prediction algorithm could help to estimate the chances of conversion from palliative re to curative major hepatectomy following significant flr hypertrophy. |
2022-12-01 |
2023-08-14 |
Not clear |
| Richard J Bell, Abdul R Hakeem, Sanjay Pandanaboyana, Brian R Davidson, Raj K Prasad, Bobby V M Dasar. Portal vein embolization versus dual vein embolization for management of the future liver remnant in patients undergoing major hepatectomy: meta-analysis. BJS open. vol 6. issue 6. 2022-11-18. PMID:36398754. |
this meta-analysis aimed to compare progression to surgery, extent of liver hypertrophy, and postoperative outcomes in patients planned for major hepatectomy following either portal vein embolization (pve) or dual vein embolization (dve) for management of an inadequate future liver remnant (flr). |
2022-11-18 |
2023-08-14 |
Not clear |
| Pouya Entezari, Beau B Toskich, Edward Kim, Siddharth Padia, Derrick Christopher, Alex Sher, Bartley Thornburg, Elias S Hohlastos, Riad Salem, Jeremy D Collins, Robert J Lewandowsk. Promoting Surgical Resection through Future Liver Remnant Hypertrophy. Radiographics : a review publication of the Radiological Society of North America, Inc. 2022-10-07. PMID:36206182. |
interventional radiologic and surgical methods to achieve flr hypertrophy are evolving, including portal vein ligation, portal vein embolization, radiation lobectomy, hepatic venous deprivation, and associating liver partition and portal vein ligation for staged hepatectomy. |
2022-10-07 |
2023-08-14 |
Not clear |
| Pouya Entezari, Beau B Toskich, Edward Kim, Siddharth Padia, Derrick Christopher, Alex Sher, Bartley Thornburg, Elias S Hohlastos, Riad Salem, Jeremy D Collins, Robert J Lewandowsk. Promoting Surgical Resection through Future Liver Remnant Hypertrophy. Radiographics : a review publication of the Radiological Society of North America, Inc. 2022-10-07. PMID:36206182. |
the authors review the techniques used to develop flr hypertrophy, focusing on technical considerations, outcomes, and the advantages and disadvantages of each approach. |
2022-10-07 |
2023-08-14 |
Not clear |
| Yan Zhu, Zhishuai Li, Jixiang Zhang, Mingqi Liu, Xiaoqing Jiang, Bin L. Identification of crucial lncRNAs and mRNAs in liver regeneration after portal vein ligation through weighted gene correlation network analysis. BMC genomics. vol 23. issue 1. 2022-09-21. PMID:36131263. |
portal vein ligation (pvl)-induced liver hypertrophy increases future liver remnant (flr) volume and improves resectability of large hepatic carcinoma. |
2022-09-21 |
2023-08-14 |
Not clear |
| Paschalis Gavriilidis, Gabriele Marangoni, Jawad Ahmad, Daniel Azoula. Simultaneous portal and hepatic vein embolization is better than portal embolization or ALPPS for hypertrophy of future liver remnant before major hepatectomy: A systematic review and network meta-analysis. Hepatobiliary & pancreatic diseases international : HBPD INT. 2022-09-13. PMID:36100542. |
the most commonly used procedure to generate hypertrophy of the functional liver remnant (flr) is portal vein embolization (pve), which does not always lead to successful hypertrophy. |
2022-09-13 |
2023-08-14 |
Not clear |
| Arash Najafi, Christoph A Binker. Transarterial Radioembolization to Impact Liver Volumetry: When and How. Cardiovascular and interventional radiology. 2022-07-21. PMID:35859212. |
although the absolute degree of flr hypertrophy seems to be comparable to portal vein embolization, the kinetic of hypertrophy is much slower after radioembolization. |
2022-07-21 |
2023-08-14 |
Not clear |
| R Korenblik, B Olij, L A Aldrighetti, M Abu Hilal, M Ahle, B Arslan, L J van Baardewijk, I Baclija, C Bent, C L Bertrand, B Björnsson, M T de Boer, S W de Boer, R P H Bokkers, I H M Borel Rinkes, S Breitenstein, R C G Bruijnen, P Bruners, M W Büchler, J C Camacho, A Cappelli, U Carling, B K Y Chan, D H Chang, J Choi, J Codina Font, M Crawford, D Croagh, E Cugat, R Davis, D W De Boo, F De Cobelli, J F De Wispelaere, O M van Delden, M Delle, O Detry, R Díaz-Nieto, A Dili, J I Erdmann, O Fisher, C Fondevila, Å Fretland, F Garcia Borobia, A Gelabert, L Gérard, F Giuliante, P D Gobardhan, F Gómez, T Grünberger, D J Grünhagen, J Guitart, J Hagendoorn, J Heil, D Heise, E Herrero, G F Hess, M H Hoffmann, R Iezzi, F Imani, J Nguyen, E Jovine, J C Kalff, G Kazemier, T P Kingham, J Kleeff, O Kollmar, W K G Leclercq, S Lopez Ben, V Lucidi, A MacDonald, D C Madoff, S Manekeller, G Martel, A Mehrabi, H Mehrzad, M R Meijerink, K Menon, P Metrakos, C Meyer, A Moelker, S Modi, N Montanari, J Navines, U P Neumann, P Peddu, J N Primrose, X Qu, D Raptis, F Ratti, F Ridouani, C Rogan, U Ronellenfitsch, S Ryan, C Sallemi, J Sampere Moragues, P Sandström, L Sarriá, A Schnitzbauer, M Serenari, A Serrablo, M L J Smits, E Sparrelid, E Spüntrup, G A Stavrou, R P Sutcliffe, I Tancredi, J C Tasse, V Udupa, D Valenti, Y Fundora, T J Vogl, X Wang, S A White, W A Wohlgemuth, D Yu, I A J Zijlstra, C A Binkert, M H A Bemelmans, C van der Leij, E Schadde, R M van Da. Dragon 1 Protocol Manuscript: Training, Accreditation, Implementation and Safety Evaluation of Portal and Hepatic Vein Embolization (PVE/HVE) to Accelerate Future Liver Remnant (FLR) Hypertrophy. Cardiovascular and interventional radiology. 2022-07-05. PMID:35790566. |
dragon 1 protocol manuscript: training, accreditation, implementation and safety evaluation of portal and hepatic vein embolization (pve/hve) to accelerate future liver remnant (flr) hypertrophy. |
2022-07-05 |
2023-08-14 |
Not clear |
| R Korenblik, B Olij, L A Aldrighetti, M Abu Hilal, M Ahle, B Arslan, L J van Baardewijk, I Baclija, C Bent, C L Bertrand, B Björnsson, M T de Boer, S W de Boer, R P H Bokkers, I H M Borel Rinkes, S Breitenstein, R C G Bruijnen, P Bruners, M W Büchler, J C Camacho, A Cappelli, U Carling, B K Y Chan, D H Chang, J Choi, J Codina Font, M Crawford, D Croagh, E Cugat, R Davis, D W De Boo, F De Cobelli, J F De Wispelaere, O M van Delden, M Delle, O Detry, R Díaz-Nieto, A Dili, J I Erdmann, O Fisher, C Fondevila, Å Fretland, F Garcia Borobia, A Gelabert, L Gérard, F Giuliante, P D Gobardhan, F Gómez, T Grünberger, D J Grünhagen, J Guitart, J Hagendoorn, J Heil, D Heise, E Herrero, G F Hess, M H Hoffmann, R Iezzi, F Imani, J Nguyen, E Jovine, J C Kalff, G Kazemier, T P Kingham, J Kleeff, O Kollmar, W K G Leclercq, S Lopez Ben, V Lucidi, A MacDonald, D C Madoff, S Manekeller, G Martel, A Mehrabi, H Mehrzad, M R Meijerink, K Menon, P Metrakos, C Meyer, A Moelker, S Modi, N Montanari, J Navines, U P Neumann, P Peddu, J N Primrose, X Qu, D Raptis, F Ratti, F Ridouani, C Rogan, U Ronellenfitsch, S Ryan, C Sallemi, J Sampere Moragues, P Sandström, L Sarriá, A Schnitzbauer, M Serenari, A Serrablo, M L J Smits, E Sparrelid, E Spüntrup, G A Stavrou, R P Sutcliffe, I Tancredi, J C Tasse, V Udupa, D Valenti, Y Fundora, T J Vogl, X Wang, S A White, W A Wohlgemuth, D Yu, I A J Zijlstra, C A Binkert, M H A Bemelmans, C van der Leij, E Schadde, R M van Da. Dragon 1 Protocol Manuscript: Training, Accreditation, Implementation and Safety Evaluation of Portal and Hepatic Vein Embolization (PVE/HVE) to Accelerate Future Liver Remnant (FLR) Hypertrophy. Cardiovascular and interventional radiology. 2022-07-05. PMID:35790566. |
the dragon 1 trial aims to assess training, implementation, safety and feasibility of combined portal- and hepatic-vein embolization (pve/hve) to accelerate future liver remnant (flr) hypertrophy in patients with borderline resectable colorectal cancer liver metastases. |
2022-07-05 |
2023-08-14 |
Not clear |
| Ruifeng Wang, Zhen Quan, Tongsen Zheng, Kai Wang, Yang Liu, Zhaoguo Han, Xiance Wang, Shiling Ma, Lianxin Liu, Wan Yee Lau, Xilin Su. Pathophysiological mechanisms of ALPPS: experimental model. The British journal of surgery. vol 109. issue 6. 2022-05-16. PMID:35576390. |
associating liver partition and portal vein ligation for staged hepatectomy (alpps) is a two-stage strategy that may increase hepatic tumour resectability and reduce postoperative liver failure rate by inducing rapid hypertrophy of the future liver remnant (flr). |
2022-05-16 |
2023-08-13 |
Not clear |
| Ryan J Ellis, Kevin C Soares, William R Jarnagi. Preoperative Management of Perihilar Cholangiocarcinoma. Cancers. vol 14. issue 9. 2022-05-14. PMID:35565250. |
patients with low flr also require intervention to induce hypertrophy, most commonly portal venous embolization, in an effort to reduce the rate of postoperative liver failure. |
2022-05-14 |
2023-08-13 |
Not clear |
| Angelo Della Corte, Guido Fiorentini, Francesca Ratti, Federica Cipriani, Carla Canevari, Marco Catena, Simone Gusmini, Luigi Augello, Diego Palumbo, Giorgia Guazzarotti, Luca Aldrighetti, Francesco De Cobell. Combining Laparoscopic Liver Partitioning and Simultaneous Portohepatic Venous Deprivation for Rapid Liver Hypertrophy. Journal of vascular and interventional radiology : JVIR. vol 33. issue 5. 2022-04-30. PMID:35489784. |
mean 1-, 2- and 4-week hypertrophy of the flr were 35%, 40.3%, and 46.4%, respectively. |
2022-04-30 |
2023-08-13 |
Not clear |
| Ruifeng Wang, Zhen Quan, Tongsen Zheng, Kai Wang, Yang Liu, Zhaoguo Han, Xiance Wang, Shiling Ma, Lianxin Liu, Wan Yee Lau, Xilin Su. Pathophysiological mechanisms of ALPPS: experimental model. The British journal of surgery. 2022-03-16. PMID:35292798. |
associating liver partition and portal vein ligation for staged hepatectomy (alpps) is a two-stage strategy that may increase hepatic tumour resectability and reduce postoperative liver failure rate by inducing rapid hypertrophy of the future liver remnant (flr). |
2022-03-16 |
2023-08-13 |
Not clear |
| Junwei Zhang, Yiyao Xu, Huayu Yang, Hanchun Huang, Jin Bian, Shitao Jiang, Xinting Sang, Yilei Mao, Haitao Zhao, Shunda Du, Haifeng Xu, Yongchang Zheng, Tianyi Chi, Xin L. Application of associating liver partition and portal vein ligation for staged hepatectomy for hepatocellular carcinoma related to hepatitis B virus: comparison with traditional one-stage right hepatectomy. Translational cancer research. vol 9. issue 9. 2022-02-04. PMID:35117902. |
associating liver partition and portal vein ligation for staged hepatectomy (alpps) has recently been suggested to cause rapid liver hypertrophy among patients having inadequate future liver remnant (flr). |
2022-02-04 |
2023-08-13 |
Not clear |
| Diego M Haberman, Oscar C Andriani, Nicole L Segaran, Mariano M Volpacchio, Maria Lucrecia Micheli, Rodolfo H Russi, Ignacio A Pérez Fernánde. Role of CT in Two-Stage Liver Surgery. Radiographics : a review publication of the Radiological Society of North America, Inc. vol 42. issue 1. 2022-01-06. PMID:34990325. |
improvements in surgical techniques such as conventional two-stage hepatectomy (tsh) with portal vein embolization and alpps (associating liver partition and portal vein ligation for staged hepatectomy) promote hypertrophy of the future liver remnant (flr), expanding resection criteria to include patients with widespread hepatic disease who were formerly not considered candidates for resection. |
2022-01-06 |
2023-08-13 |
Not clear |